Amundi
ARCT icon

Amundi’s Arcturus Therapeutics ARCT Stock Holding History

Amundi’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-950
Closed -$9.01K – 1687
2025
Q1 		$9.01K Sell
950
-45
-5% -$714 ﹤0.01% 1887
2024
Q4 		$18.9K Buy
995
+54
+6% +$1.02K ﹤0.01% 1892
2024
Q3 		$21.1K Hold
941
– – ﹤0.01% 1904
2024
Q2 		$20.6K Sell
941
-720
-43% -$21.8K ﹤0.01% 1845
2024
Q1 		$43.7K Hold
1,661
– – ﹤0.01% 1854
2023
Q4 		$54.7K Hold
1,661
– – ﹤0.01% 1873
2023
Q3 		$38.1K Hold
1,661
– – ﹤0.01% 1893
2023
Q2 		$47.6K Buy
+1,661
New +$45.2K ﹤0.01% 1900
2021
Q4 		– Sell
-648
Closed -$31K – 1677
2021
Q3 		$31K Buy
+648
New +$29K ﹤0.01% 1543

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return